Pancreatic cancer in 2021: What you need to know to win

V Tonini, M Zanni - World Journal of Gastroenterology, 2021 - pmc.ncbi.nlm.nih.gov
Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …

[HTML][HTML] Regulatory mechanisms of one-carbon metabolism enzymes

B Petrova, AG Maynard, P Wang, N Kanarek - Journal of Biological …, 2023 - Elsevier
One-carbon metabolism is a central metabolic pathway critical for the biosynthesis of several
amino acids, methyl group donors, and nucleotides. The pathway mostly relies on the …

Artificial intelligence analysis of gene expression predicted the overall survival of mantle cell lymphoma and a large pan-cancer series

J Carreras, N Nakamura, R Hamoudi - Healthcare, 2022 - mdpi.com
Mantle cell lymphoma (MCL) is a subtype of mature B-cell non-Hodgkin lymphoma
characterized by a poor prognosis. First, we analyzed a series of 123 cases (GSE93291). An …

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

L Wang, C Shi, J Yu, Y Xu - Cancer cell international, 2022 - Springer
Background Hepatocellular carcinoma (HCC) is the most common type of primary liver
cancer and one of the major causes of cancer-related death. Thymidylate synthase (TYMS) …

Integrated WGCNA and PPI network to screen hub genes signatures for infantile hemangioma

M Xu, T Ouyang, K Lv, X Ma - Frontiers in genetics, 2021 - frontiersin.org
Background Infantile hemangioma (IH) is characterized by proliferation and regression.
Methods Based on the GSE127487 dataset, the differentially expressed genes (DEGs) …

TYMS-TM4SF4 axis promotes the progression of colorectal cancer by EMT and upregulating stem cell marker

F Zhang, J Ye, W Guo, F Zhang… - American Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
Background: The expression of thymidylate synthase (TYMS) is significantly up-regulated in
various cancers and associated with the poor prognosis of patients. However, the role of …

[HTML][HTML] Thymidylate synthase overexpression drives the invasive phenotype in colon cancer cells

WM Ciszewski, M Chmielewska-Kassassir, LA Wozniak… - Biomedicines, 2022 - mdpi.com
Thymidylate synthase (TYMS) is the crucial enzymatic precursor for DNA biosynthesis and,
therefore, the critical target for numerous types of chemotherapy, including the most …

Screening and discovery of new potential biomarkers and small molecule drugs for cervical cancer: a bioinformatics analysis

HZ Qiu, J Huang, CC **ang, R Li… - … in Cancer Research …, 2020 - journals.sagepub.com
Background: Cervical cancer (CC) is the second most common type of malignant tumor
survival rate is low in advanced stage, metastatic, and recurrent CC patients. This study …

Serum exosomal EphA2 is a prognostic biomarker in patients with pancreatic cancer

Q Wei, Z Li, H Feng, L Ren - Cancer management and research, 2021 - Taylor & Francis
Background Pancreatic cancer (PC) is one of the worst prognoses amongst all malignant
diseases. It is therefore of great significance to identify biomarkers with predictive clinical …

A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma

SG Kisling, P Atri, A Shah, JL Cox… - Clinical Cancer …, 2023 - aacrjournals.org
Purpose: Despite the significant association of molecular subtypes with poor prognosis in
patients with pancreatic ductal adenocarcinoma (PDAC), few efforts have been made to …